Search

Your search keyword '"Van Vlierberghe, Hans"' showing total 920 results

Search Constraints

Start Over You searched for: Author "Van Vlierberghe, Hans" Remove constraint Author: "Van Vlierberghe, Hans"
920 results on '"Van Vlierberghe, Hans"'

Search Results

1. Coaching doctors to improve ethical decision-making in adult hospitalized patients potentially receiving excessive treatment. The CODE stepped-wedge cluster randomized controlled trial

2. Contributors

6. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

7. Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

9. AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool

11. THU-102-YI Specific glycomic profiles can identify patients at risk of poor transplant-free survival in primary biliary cholangitis

12. FRI-475-YI NADPH oxidase 1 inhibition as therapeutic strategy in hepatocellular carcinoma: insights from human-relevant models

13. OS-089-YI Transgenerational maternal obesity induces mitochondrial dysfunction and aggravates MASLD, which can be reversed by metabolic drug candidates

14. THU-123-YI External validation of the international autoimmune hepatitis group response criteria in a multicentric real-world cohort

17. WED-531 The double-edged sword of bariatric surgery: extending the excluded limb can trigger bacterial translocation, liver inflammation and death

19. Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1: A Landmark Analysis

20. R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation

21. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

24. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches

28. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria

32. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

36. Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide

38. Systematic review: Glycomics as diagnostic markers for hepatocellular carcinoma.

39. Patients hospitalized with alcohol‐related liver disease and prior bariatric surgery are more prone to develop acute‐on‐chronic liver failure

40. Osteopontin characterizes bile duct–associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis

43. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

48. The pan-PPAR agonist lanifibranor decreases portal pressure in models of both hepatic and prehepatic portal hypertension

50. The prognosis of hepatitis delta infections in Belgium is poor and determined by the hepatitis delta viremia

Catalog

Books, media, physical & digital resources